We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Diagnosis of Variceal Bleeding and Its Control in Cirrhosis

This study has been terminated.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00188097
First Posted: September 16, 2005
Last Update Posted: January 19, 2006
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
University Hospital, Angers
  Purpose
The aim of the study was to determine the independent predictors of variceal bleeding and control of bleeding in cirrhosis as no scientific assessment have been perfomed until now

Condition Intervention
Cirrhosis Behavioral: Diagnosis of variceal bleeding and dits control in cirrhosis

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Diagnosis of Variceal Bleeding and Its Control in Cirrhosis

Resource links provided by NLM:


Further study details as provided by University Hospital, Angers:

Primary Outcome Measures:
  • variceal bleeding

Estimated Enrollment: 400
Study Start Date: November 1999
Estimated Study Completion Date: June 2002
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 75 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Cirrhotic patients admitted for an acute complication of cirrhosis
  • admission ≤ 6 hours of inclusion

Exclusion Criteria:

  • Child-Pugh score > 13
  • Digestive hemorrhage
  • Non cirrhotic portal hypertension
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00188097


Sponsors and Collaborators
University Hospital, Angers
Investigators
Principal Investigator: Paul Cales, PHD UH Angers
  More Information

ClinicalTrials.gov Identifier: NCT00188097     History of Changes
Other Study ID Numbers: PHRC 03-04
First Submitted: September 12, 2005
First Posted: September 16, 2005
Last Update Posted: January 19, 2006
Last Verified: August 2005

Additional relevant MeSH terms:
Fibrosis
Liver Cirrhosis
Pathologic Processes
Liver Diseases
Digestive System Diseases